Total trials
167
Active
35
Phase 3
8
Total enrollment
16,243,058
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Low calorie meal replacement plan | — | — | — | — | — | 1 | |
| Sparsentan | — | — | — | — | — | 1 |
Next readouts
- 2026-06-30
- 2027-12-31
Top conditions
- Diabetes Mellitus, Type 213
- Cardiovascular Diseases9
- Asthma7
- Coronary Artery Disease7
- Type 2 Diabetes7
- Heart Failure6
- Heart Failure With Preserved Ejection Fraction5
- Peripheral Arterial Disease5
Frequently asked questions about University of Leicester
- How many clinical trials does University of Leicester have on ClinicalTrials.gov?
- University of Leicester is listed as the lead sponsor on 167 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Leicester's trials are in Phase 3?
- 8 of University of Leicester's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does University of Leicester focus on?
- University of Leicester's most-studied conditions on ClinicalTrials.gov are Diabetes Mellitus, Type 2, Cardiovascular Diseases, Asthma, Coronary Artery Disease, Type 2 Diabetes.
- When are University of Leicester's next clinical trial readouts?
- University of Leicester has 2 upcoming primary-completion readouts tracked here; the soonest is “A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction”, expected around 2026-06-30.